🇺🇸 FDA
Patent

US 8440621

Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

granted A61KA61K38/1767A61K47/542

Quick answer

US patent 8440621 (Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels) held by The Regents of the University of California expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/1767, A61K47/542, A61K47/6415, A61P